Mubalake Abudoureyimu

University of Macau — MO

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index327citations22works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(8), MicroRNA in disease regulation(6), Ferroptosis and cancer prognosis(6), RNA modifications and cancer(6), Circular RNAs in diseases(6)

Publications21 total

Retraction Note: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
Cell Death and Disease·2025Open Access
Abstract 3067: The long non-coding RNA CDH3-AS1 facilitates gemcitabine resistance and lung metastasis via TGFβ activation in pancreatic ductal adenocarcinoma
Cancer Research·2025
Aurora-A promotes lenvatinib resistance experimentally through hsa-circ-0058046/miR-424-5p/FGFR1 axis in hepatocellular carcinoma
International Journal of Immunopathology and Pharmacology·2025· 1 citedOpen Access
Aurora-A inhibitor synergistically enhances the inhibitory effect of anlotinib on hepatocellular carcinoma
Biochemical and Biophysical Research Communications·2023· 4 cited
Aurora-a inhibitor synergistically enhances the inhibitory effect of anlotinib on hepatocellular carcinoma
Research Square (Research Square)·2022Open Access
Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
Cell Death and Disease·2021· 1 citedOpen Access
RETRACTED ARTICLE: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
Cell Death and Disease·2021· 25 citedOpen Access
Immune prognostic implications of PSMD14 and its associated genes signatures in hepatocellular carcinoma
Biocell·2021· 2 citedOpen Access
Immune Prognostic Implications of PSMD14 and its Associated Genes Signatures in Hepatocellular Carcinoma
Research Square (Research Square)·2020Open Access
Immune Prognostic Implications of PSMD14 and Its Associated Genes Signatures in Hepatocellular Carcinoma
Research Square (Research Square)·2020Open Access
The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer
Life Sciences·2020· 29 citedOpen Access
Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
Frontiers in Oncology·2020Open Access
Immune prognostic implications of PSMD14 and its associated genes signatures in hepatocellular carcinoma
2020Open Access
Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
Frontiers in Oncology·2020· 2 citedOpen Access
The role of Aurora-A in human cancers and future therapeutics.
PubMed·2020· 55 citedOpen Access
Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
PubMed·2020· 11 citedOpen Access
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
Frontiers in Oncology·2019· 52 citedOpen Access
Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
Frontiers in Oncology·2019· 24 citedOpen Access
FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
Molecular Therapy — Nucleic Acids·2019· 56 citedOpen Access
Recent progress in the emerging role of exosome in hepatocellular carcinoma
Cell Proliferation·2018· 44 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Rui Wang(15), Xiaoyuan Chu(15), Xinrong Lin(11), Chuan Tian(11), Yongting Lai(7), Yingru Zhi(5), Hao Zhou(5), Ting Wang(3), Bing Feng(3), Ting Wang(3), Ting Wang(2), Bing Feng(2), Hao Zhou(2), Xinrong Lin(2), Fan Pan(2), Liping Hao(2), Xiaoyuan Chu(2), Xiaosong Xiang(1), Liping Hao(1), Bing Feng(1)